STOCKHOLM, Aug 26 (Reuters) - Swedish radiation therapy equipment maker Elekta EKTAb.ST on Wednesday reported bigger-than-expected fiscal first-quarter profit despite a decline in sales due to the COVID-19 pandemic.
Operating profit jumped 42% from a year earlier to 335 million crowns ($38.21 million). Four analysts polled by Refinitiv had on average forecast a profit of 172 million crowns.
Profit before interest, tax and amortisation grew 23% to 551 million crowns.
($1 = 8.7668 Swedish crowns)
(Reporting by Anna Ringstrom, Editing by Supantha Mukherjee)
((anna.ringstrom@thomsonreuters.com; +46 8 502 423 74; Reuters Messaging: anna.ringstrom.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
